333 related articles for article (PubMed ID: 34664843)
1. BRAF V600E mutation and the Bethesda System for Reporting Thyroid Cytopathology of fine-needle aspiration biopsy for distinguishing benign from malignant thyroid nodules.
Sheng D; Yu X; Li H; Zhang M; Chen J
Medicine (Baltimore); 2021 Sep; 100(37):e27167. PubMed ID: 34664843
[TBL] [Abstract][Full Text] [Related]
2. Fine-needle Aspiration Washout Precipitation Specimens: An Acceptable Supplement to Genetic Mutation Detection of Thyroid Nodules.
Cui Y; Huang X; Guo J; Zhang N; Liang J; Zhang Y; Liao Y; He D
Technol Cancer Res Treat; 2021; 20():15330338211057982. PubMed ID: 34806478
[No Abstract] [Full Text] [Related]
3. BRAF
Chen H; Song A; Wang Y; He Y; Tong J; Di J; Li C; Zhou Z; Cai X; Zhong D; Da J
Cancer Med; 2022 Jan; 11(1):40-49. PubMed ID: 34851044
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic values of BRAF(V600E) mutation analysis and Bethesda system for reporting thyroid cytopathology in thyroid nodules with TIRADS 4 and 5].
Han Y; Zhao BW; Li SY; Lyu JG; Shou JD; Xu HS; Lou HY; Xu LL; Gao L; Xu SX; Zhu J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 52(9):686-691. PubMed ID: 28910894
[No Abstract] [Full Text] [Related]
5. Diagnostic Value and Challenges of BRAF V600E Molecular Testing and Thyroid Fine-Needle Aspiration Cytology: A Retrospective Study from a Tertiary Institution in Southern Hunan Province, China.
Lan Z; Yang F; Zhang J; Lan Y; Li H; He R
Acta Cytol; 2023; 67(6):629-638. PubMed ID: 37708867
[TBL] [Abstract][Full Text] [Related]
6. Real-life utility of five-gene panel test in preoperative thyroid fine-needle aspiration biopsy: a large cohort of 740 patients study.
Tang J; Ma J; Xi X; Wang L; Li H; Huo S; Zhang B
Endocrine; 2023 Jun; 80(3):552-562. PubMed ID: 36542267
[TBL] [Abstract][Full Text] [Related]
7. Value of
Chen X; Zhou Q; Wang F; Zhang F; Du H; Zhang Q; Wu W; Gong X
AJNR Am J Neuroradiol; 2018 Dec; 39(12):2360-2365. PubMed ID: 30498021
[TBL] [Abstract][Full Text] [Related]
8. Significance of FNAC, BRAF mutation, and intraoperative frozen section in surgical decision-making of thyroid nodules.
Zhu Z; Su C; Chen G; Wan F; Jin M; Duan X; Wang Y; Wang G
Diagn Cytopathol; 2023 Jul; 51(7):441-448. PubMed ID: 37042168
[TBL] [Abstract][Full Text] [Related]
9. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
Rossi M; Buratto M; Bruni S; Filieri C; Tagliati F; Trasforini G; Rossi R; Beccati MD; Degli Uberti EC; Zatelli MC
J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic Value of American Thyroid Association Guidelines,American College of Radiology Thyroid Imaging Reporting and Data System,and Chinese Thyroid Imaging Reporting and Data System Alone and Combined With BRAF
Lin Y; Luo YK; Li J; Ren XY; Wang HW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):921-928. PubMed ID: 38173102
[TBL] [Abstract][Full Text] [Related]
11.
Zhu Y; Wu H; Huang B; Shen X; Cai G; Gu X
Gland Surg; 2020 Oct; 9(5):1674-1684. PubMed ID: 33224845
[TBL] [Abstract][Full Text] [Related]
12. BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis.
Nam SY; Han BK; Ko EY; Kang SS; Hahn SY; Hwang JY; Nam MY; Kim JW; Chung JH; Oh YL; Shin JH
Thyroid; 2010 Mar; 20(3):273-9. PubMed ID: 20187782
[TBL] [Abstract][Full Text] [Related]
13. Additional BRAF mutation analysis may have additional diagnostic value in thyroid nodules with "suspicious for malignant" cytology alone even when the nodules do not show suspicious US features.
Seo JY; Kim EK; Kwak JY
Endocrine; 2014 Sep; 47(1):283-9. PubMed ID: 24452872
[TBL] [Abstract][Full Text] [Related]
14. BRAF mutation analysis by ARMS-PCR refines thyroid nodule management.
Li X; Li E; Du J; Wang J; Zheng B
Clin Endocrinol (Oxf); 2019 Dec; 91(6):834-841. PubMed ID: 31441082
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of BRAF(V600E) mutation analysis of thyroid nodules according to ultrasonographic features and the time of aspiration.
Moon HJ; Kim EK; Chung WY; Choi JR; Yoon JH; Kwak JY
Ann Surg Oncol; 2011 Mar; 18(3):792-9. PubMed ID: 20945104
[TBL] [Abstract][Full Text] [Related]
16. BRAF V600E as an accurate marker to complement fine needle aspiration (FNA) cytology in the guidance of thyroid surgery in the Chinese population: evidence from over 1000 consecutive FNAs with follow-up.
Zhao Q; Wang Y; Ye Q; Wang P; Rao J
Jpn J Clin Oncol; 2021 Apr; 51(4):590-594. PubMed ID: 33237284
[TBL] [Abstract][Full Text] [Related]
17. Value of TIRADS, BSRTC and FNA-BRAF V600E mutation analysis in differentiating high-risk thyroid nodules.
Zhang YZ; Xu T; Cui D; Li X; Yao Q; Gong HY; Liu XY; Chen HH; Jiang L; Ye XH; Zhang ZH; Shen MP; Duan Y; Yang T; Wu XH
Sci Rep; 2015 Nov; 5():16927. PubMed ID: 26597052
[TBL] [Abstract][Full Text] [Related]
18. Effect of BRAF V600E mutation detection of fine-needle aspiration biopsy on diagnosis and treatment guidance of papillary thyroid carcinoma.
Qi W; Shi C; Zhang P; Feng L; Wang J; Chen D
Pathol Res Pract; 2020 Aug; 216(8):153037. PubMed ID: 32703500
[TBL] [Abstract][Full Text] [Related]
19. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.
Paek SH; Kim BS; Kang KH; Kim HS
World J Surg Oncol; 2017 Nov; 15(1):202. PubMed ID: 29132392
[TBL] [Abstract][Full Text] [Related]
20. BRAF
Lu Y; Guo X; Yang M; Wang K; Cao G; Liu Y; Hou X; Chen L; Liang K
Sci Rep; 2023 Oct; 13(1):17129. PubMed ID: 37816788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]